We are live on
!
Find out more
G
Gainplan Portfolio holdings
AUM
$258M
1-Year Est. Return
17.9%
This Fund
S&P 500
This Quarter
Est. Return
-23.51%
1 Year Est. Return
+17.9%
3 Year Est. Return
+102.86%
5 Year Est. Return
+99.91%
10 Year Est. Return
+262.13%
AUM
$102M
AUM Growth
-$82.2M
(-45%)
Cap. Flow
-$57.1M
Cap. Flow
% of AUM
-55.74%
Top 10 Holdings %
Top 10 Hldgs %
98.1%
Holding
32
New
9
Increased
7
Reduced
2
Closed
14
Avg Time Held Equity + Options
1.4
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.4
quarters
Avg Time Held Equity only
1.4
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily Small Cap Bull 3x ETF
TNA
|
+$34.9M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$10M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$8.16M |
| 4 |
Direxion Daily S&P 500 Bull 3x ETF
SPXL
|
+$3.22M |
| 5 |
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
|
+$672K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$37.9M |
| 2 |
Schwab US Large-Cap Value ETF
SCHV
|
+$30M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$26.6M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$11.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$6.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.3% |
| 2 | Healthcare | 0.7% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Schwab US Large-Cap Value ETF
SCHV
$15.4B
| – | – |
-1,607,178
| Closed | -$30M | – |
|
27
CALL
Take-Two Interactive
TTWO
$37.5B
| – | – |
-22,500
| Closed | -$1K | – |
|
|
28
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| – | – |
-70,089
| Closed | -$6.72M | – |
|
29
CALL
Turtle Beach Corp
TBCH
$260M
| – | – |
-26,500
| Closed | -$40K | – |
|
|
30
Turtle Beach Corp
TBCH
$260M
| – | – |
-22,000
| Closed | -$439K | – |
|
|
AERI
31
DELISTED
Aerie Pharmaceuticals
AERI
| – | – |
-4,500
| Closed | -$277K | – |
|
|
NIHD
32
CALL
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| – | – |
-26,200
| Closed | -$21K | – |
|
Similar funds
GHP
ROC
IMC
FCM
EA
PHM
LAS
DC
Gainplan's Q4 2018 Portfolio in Review
As of Q4 2018, Gainplan held 32 positions worth $102M, down 45% from $185M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Gainplan withdrew a net $57.1M in Q4 2018, closing 14 positions and reducing 2 holdings. Its most notable exit was Schwab US Large-Cap Value ETF, an estimated $30M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, down from 99% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Gainplan opened a new position in Direxion Daily Small Cap Bull 3x ETF worth $24.1M.
- Gainplan's largest Q4 2018 buy was Direxion Daily Small Cap Bull 3x ETF: 572,376 shares worth $24.1M.
- Gainplan added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $8.16M increase.
- Gainplan's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $37.9M.
- Gainplan fully exited Schwab US Large-Cap Value ETF in Q4 2018, selling an estimated $30M.
- Gainplan's ten largest holdings make up 98% of its $102M portfolio in Q4 2018.
- Gainplan opened 9 new positions and closed 14 in Q4 2018.
- Gainplan's portfolio value fell 45% quarter-over-quarter to $102M.
Based on Gainplan's 13F filing for Q4 2018, filed 8 Feb 2019.